Plunkard Jessica C M, Jimenez Isabel A, Tarwater Patrick M, Craney Morgan C, Villano Jason S
Department of Molecular and Comparative Pathobiology, The Johns Hopkins University School of Medicine, Baltimore, Maryland.
School of Public Health, Texas A&M University, College Station, Texas; and.
J Am Assoc Lab Anim Sci. 2024 Aug 20;63(5):552-64. doi: 10.30802/AALAS-JAALAS-24-000011.
Buprenorphine hydrochloride (Bup-HCl) is a common injectable opioid analgesic. In ferrets, Bup-HCl must be administered every 8 to 12 h to maintain clinical efficacy. Extended-release analgesics offer multiple advantages, including reduced handling and injection frequency, improved compliance, and increased protection from end-of-dose failure. Although efficacy of extended-release buprenorphine formulations has been demonstrated in other species, their use in the domestic ferret has not been investigated. In this study, we evaluated the pharmacokinetics of a compounded polymeric formulation of buprenorphine (Bup-ER) and a pharmaceutical-grade, FDA-indexed liposomal suspension (Bup-XR). Two doses each of Bup-ER (0.12 and 0.2 mg/kg) and Bup-XR (0.2 and 0.6 mg/kg SC) were administered to young adult female ferrets and plasma concentrations were measured between 0 and 96 h ( = 4 animals per timepoint). All doses of both drugs achieved therapeutic plasma levels by 30 min. Furthermore, high-dose Bup-XR maintained therapeutic levels for 72 h, followed by high-dose Bup-ER (less than 48 h), low-dose Bup-XR (24 h), and low-dose Bup-ER (less than 24 h). In this study, we also developed a pain scoring system and utilized this to compare analgesic efficacy between single high-dose Bup-XR (0.6 mg/kg SC) and a standard postoperative course of Bup-HCl (0.02 mg/kg SC every 10 to 12 h for 8 doses) after ovariohysterectomy. Ferrets receiving Bup-XR had significantly lower respiratory rate and posture scores in the first 24 h postoperatively than did those that received Bup-HCl and were less likely to react to palpation of the surgical incision. Of note, ferrets that received high-dose Bup-ER had a significantly higher incidence of injection site reactions than ferrets that received Bup-HCl ( = 0.0137). This study demonstrates that a single dose of Bup-XR (0.6 mg/kg SC) is a safe and effective analgesic in female ferrets, with a duration of action up to 72 h and minimal side effects, offering a refinement to analgesia in this species.
盐酸丁丙诺啡(Bup-HCl)是一种常见的注射用阿片类镇痛药。在雪貂中,必须每8至12小时注射一次Bup-HCl以维持临床疗效。缓释镇痛药具有多种优势,包括减少处理和注射频率、提高依从性以及增强预防剂量末期失效的能力。尽管缓释丁丙诺啡制剂在其他物种中的疗效已得到证实,但尚未对其在宠物雪貂中的应用进行研究。在本研究中,我们评估了一种复合的丁丙诺啡聚合物制剂(Bup-ER)和一种医药级、经美国食品药品监督管理局(FDA)认证的脂质体混悬液(Bup-XR)的药代动力学。分别给成年雌性幼龄雪貂注射两种剂量的Bup-ER(0.12和0.2 mg/kg)和Bup-XR(0.2和0.6 mg/kg皮下注射),并在0至96小时内测量血浆浓度(每个时间点n = 4只动物)。两种药物的所有剂量在30分钟内均达到治疗性血浆水平。此外,高剂量的Bup-XR可维持治疗水平达72小时,其次是高剂量的Bup-ER(少于48小时)、低剂量的Bup-XR(24小时)和低剂量的Bup-ER(少于24小时)。在本研究中,我们还开发了一种疼痛评分系统,并利用该系统比较了单次高剂量Bup-XR(0.6 mg/kg皮下注射)与标准术后Bup-HCl疗程(0.02 mg/kg皮下注射,每10至12小时一次,共8剂)在卵巢子宫切除术后的镇痛效果。接受Bup-XR的雪貂在术后头24小时内呼吸频率和姿势评分显著低于接受Bup-HCl的雪貂,且对手术切口触诊的反应可能性较小。值得注意的是,接受高剂量Bup-ER的雪貂注射部位反应的发生率显著高于接受Bup-HCl的雪貂(P = 0.0137)。本研究表明,单次剂量的Bup-XR(0.6 mg/kg皮下注射)在雌性雪貂中是一种安全有效的镇痛药,作用持续时间长达72小时且副作用最小,为该物种的镇痛提供了一种优化方法。